Evidence-based review of the use of the pulmonary artery catheter: impact data and complications.
The pulmonary artery catheter (PAC) was introduced in 1971 for the assessment of heart function at the bedside. Since then it has generated much enthusiasm and controversy regarding the benefits and potential harms caused by this invasive form of hemodynamic monitoring. This review discusses all clinical studies conducted during the past 30 years, in intensive care unit settings or post mortem, on the impact of the PAC on outcomes and complications resulting from the procedure. Although most of the historical observational studies and randomized clinical trials also looked at PAC-related complications among their end-points, we opted to review the data under two main topics: the impact of PAC on clinical outcomes and cost-effectiveness, and the major complications related to the use of the PAC.
Hadian
Mehrnaz
M
Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Pinsky
Michael R
MR
D002407:Catheterization, Swan-Ganz / Q000191:economics; D002985:Clinical Protocols; D003362:Cost-Benefit Analysis; D003422:Critical Care / Q000379:methods* / Q000592:standards; D005069:Evaluation Studies as Topic; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods; D016896:Treatment Outcome